Prochlorperazine Maleate Buccal Tablets

Form: Buccal tablets

Strength: 3 mg

Reference Brands: US: Compazine®, Procomp®; EU: Stemetil®, Buccastem®

Category: Antipsychotropic Drugs

Prochlorperazine maleate buccal tablets are approved in the USA by the FDA for the management of severe nausea and vomiting, including those associated with migraines and chemotherapy. The buccal route provides prolonged therapeutic levels with convenient, non-invasive administration. In the EU, these tablets are regulated under centralized or national procedures, depending on the member state, and require GMP-compliant manufacturing and detailed pharmacovigilance data. The formulation offers an alternative for patients who cannot tolerate oral or injectable forms. Explore other forms of Prochlorperazine at Pharmatradz.com.